{"name":"Omega Therapeutics","slug":"omega-therapeutics","ticker":"","exchange":"","domain":"","description":"Omega Therapeutics is a biotechnology company focused on developing novel therapies for various diseases. Despite having three drug candidates in its pipeline, all are currently discontinued, indicating a shift in strategy or challenges in clinical development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":3094000,"revenueGrowth":49.3,"grossMargin":0,"rdSpend":77169000,"netIncome":-97428000,"cash":204366000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1CbWV0N05tcG9EcnlOdVY4OW51QklydUg4V29jT1p2TWI4QzFDeFE3cUpYYlRPSF9jeG1yU29jWEc2b0NyTEgzeV8xdkFSdVQ5MmpLeVAwVDMxLWRvdGc?oc=5","date":"2026-01-01","type":"pipeline","source":"ACS Publications","summary":"Ionic Liquids in Pharmaceuticals: A Scoping Review of Formulation Strategies - ACS Publications","headline":"Ionic Liquids in Pharmaceuticals: A Scoping Review of Formulation Strategies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTFAzWXpaRHVxLVhYMktyaHducTgtS2k4aXl5STFaSHVxcVVVU2t1WXBGVVJkbE9KVXgyZlZZbGFHeFJUSmlnbFZBUzQtQjJyamQwaXZSWmJmNm1fRk0telNiOG82T1JiTElZZmg4?oc=5","date":"2025-12-31","type":"pipeline","source":"Market.us","summary":"Omega 3 Prescription Drugs Market Size, Share | CAGR of 7.8% - Market.us","headline":"Omega 3 Prescription Drugs Market Size, Share | CAGR of 7.8%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5GTHhiX3NjNnk2dU80ejNRTE1hMVZtZG1felBhYTBNSm9vV2xhZzhGdjl2U1Q0cmlqeFc1VnpkODNyaW8yM29XaXBXUmZTMkQxZTdnY1pmR1dzYzRw?oc=5","date":"2025-08-08","type":"pipeline","source":"EurekAlert!","summary":"Reducing the global burden of liver cancer: Recommendations from The Lancet commission - EurekAlert!","headline":"Reducing the global burden of liver cancer: Recommendations from The Lancet commission - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOY3ZJT0phS1kxd0lrTktLd2d2WDV4M3JUZnhkcDA5MHBaT3VNbUZ4QmFpTGJGeTFFYldQMDY5TzBxekg2b2MwRWF0MUtubkNKVkRma3hkWjhxUWJiZzZ3VUdJSUo1cWhTSlcxb3lGa0lTY1dWemdWajV0Q0NCY05QelV0RlZBckJTemoxTE1BcFJBb3BhckRsbXdoN1lISU1lS2RtQQ?oc=5","date":"2025-07-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Life sciences VC Omega Funds closes $647m funding round - Pharmaceutical Technology","headline":"Life sciences VC Omega Funds closes $647m funding round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"Endpoints News","summary":"IPO Tracker (2021) - Endpoints News","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOR2ZvUVQtSVdvaFg4MVNOaGlFU0JGd2RJNUc5OUEyVVA1Z0xZQkpnMXZPNGpjLU1DVEh0WFR3azFBbGJBcXEtQkhXbXNReGdPYzA4Rl9rME9UcHA1SDVZdlBrYXlwaFlEeHpiQ1dHZXpNeUFvMUlPSDhfYkpjZ0c1TGVSWEdieTRwbk1fenpTMEZiSzBlaGJwQ0kxUW8xSHFmYm13UzFFZHBpNnB6QU82dW9xam85VWRfZHF6LU1Cb1JGQ3FFeFozMDdpbkp4QTFLMjd6TXQ3R1Y0N3dibTd6WTRFN3h0YnFuZHRLb2c4MVdQMEtZdXFsQTlR?oc=5","date":"2025-05-06","type":"pipeline","source":"PR Newswire","summary":"Ousia Pharma Secures Substantial Seed Financing Led by Omega Funds to Advance Groundbreaking Obesity Treatment - PR Newswire","headline":"Ousia Pharma Secures Substantial Seed Financing Led by Omega Funds to Advance Groundbreaking Obesity Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPcFdLbk9qTkFCVVIxd1Myb2psX0U3clVuVnJVQ2JjNnlXa2hkZ3FCajhaaFpvcHhkNFVWSlppRjlhZDNyblY2ZG1jenlJdUduc0E0eXhiSjR2eUVmUXQ5ZlhSejRyRFVvbWNrS0phYmJBT1BsSm82RHFRMFh2OG9IS1hHNTNhd1gwamYyM1IwSnFwU3Jq?oc=5","date":"2025-04-17","type":"earnings","source":"BioSpace","summary":"Q1 Biopharma Layoffs Hit California, Massachusetts Hard - BioSpace","headline":"Q1 Biopharma Layoffs Hit California, Massachusetts Hard","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1LQ3N0MXoxLUFoQVZHaHlSSGlXX1FlcHFGNWI2aXFjZDlJbV9rSENpeF92djVsbTIwX3hIV3hyMGMzSlo2Z2dyYVVXaFJjSk4zVlVVdU1Bb3FhYnhJX1FJ?oc=5","date":"2025-03-13","type":"pipeline","source":"Nature","summary":"Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseases - Nature","headline":"Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse","sentiment":"neutral"},{"date":"2025-02-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-02-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxON1h1QmJJaDNKWWRsM2F3S2I0dUlYaEtrMExsd3Rzb21HSVZGMG9iYk8wMmM5cmpNUVJENm51Q2xER1pQMnFCQWhlZWpMNjVVWjJCaGlWQmZlWUxWQm1QYkZZRHNReXVlbGdUazdFOGpiOUlfTTlqdzlHOV9BSXhPMndrckxRQllmNE0tRmRlVTF3VXpQSTFBX1ozOGlsOVNT?oc=5","date":"2025-02-04","type":"pipeline","source":"BioPharma Dive","summary":"Flagship-backed Omega signals it’s headed toward bankruptcy - BioPharma Dive","headline":"Flagship-backed Omega signals it’s headed toward bankruptcy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNS2EyS0RyODJkNXdPSEJnOGZlRmREbGU0Y1NnMVBaZXkydnBUNUR5a0tHdlhkOVVIdjNaT3BDckwzZUtXYy1TVTY0V1ZOaGhiNHNBZUo3Q2pzaXBkaDlwVUV4aVpiMGhvbnFfS3FVVjRBMnFfd3poaFJkMWpiN29CRW9KZUJSOFVDWUZFNWE3V0ZIczdLeUlvbnZ1WF91djYxZ0liOUZhRUkzX2RsVHN0QjZMMXVQQThBTHN5UXZ3UkM2WGxfdm9xdw?oc=5","date":"2025-02-04","type":"pipeline","source":"Fierce Biotech","summary":"Flagship's Omega sinks toward bankruptcy, lays off staff 13 months after inking Novo obesity pact - Fierce Biotech","headline":"Flagship's Omega sinks toward bankruptcy, lays off staff 13 months after inking Novo obesity pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5YekFueGwxc29qTkdNNk1RNnpuOHlQbjRINVlwQVpzcmZyc04yMFppMWpjWTNuWWJWSzZxUnZCNjhFVzYyRnk5SFRGYUQ5YjB4cGxr?oc=5","date":"2025-02-04","type":"pipeline","source":"FirstWord Pharma","summary":"Turnstone, Omega cut staff in separate struggles to stay afloat - FirstWord Pharma","headline":"Turnstone, Omega cut staff in separate struggles to stay afloat","sentiment":"neutral"},{"date":"2025-02-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-01-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":3094000,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":3094000,"period":"2023-12-31"},{"value":2073000,"period":"2022-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":77169000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-97428000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":204366000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}